|
Volumn 34, Issue 5, 2002, Pages 1504-1506
|
Cyclosporine-based quadruple induction therapy versus tacrolimus-based dual immunosuppression after liver transplantation: Ten-year follow-up
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
METHYLPREDNISOLONE;
PREDNISOLONE;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
CYCLOSPORIN;
ADOLESCENT;
ADULT;
AGED;
CAUSE OF DEATH;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FOLLOW UP;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART FAILURE;
HUMAN;
HYPOGLYCEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER CELL CARCINOMA;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
POSTOPERATIVE INFECTION;
POSTOPERATIVE THROMBOSIS;
PRIORITY JOURNAL;
REOPERATION;
SURVIVAL RATE;
TREATMENT OUTCOME;
ARTICLE;
COMPARATIVE STUDY;
DRUG COMBINATION;
IMMUNOLOGY;
MORTALITY;
RETROSPECTIVE STUDY;
TIME;
COMPARATIVE STUDY;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
HUMAN;
LIVER TRANSPLANTATION;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TACROLIMUS;
TIME FACTORS;
HUMANS;
|
EID: 0035993616
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02949-4 Document Type: Conference Paper |
Times cited : (2)
|
References (6)
|